Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy of Faricimab in patients with neovascular age-related macular degeneration; the study is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Faricimab (faricimab)

Snippet

Sponsor: Junyeop Lee | Conditions: Macular Degeneration | Phase 4 | Status: NOT_YET_RECRUITING